RASRx-1902

N/A

Report date: 2024/03/22 16:54:52
NME

Base Information

Drug NameRASRx-1902
Drug Alias NameRASRx-1902RASRx1902
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene Mas agonists
TargetsProto-oncogene Mas
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRASRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesRASRx Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A